We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
-$86.4M
Cap. Flow
-$26.2M
Cap. Flow %
-2.15%
Top 10 Hldgs %
42.8%
Holding
275
New
12
Increased
27
Reduced
50
Closed
12

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.07M
2
CSCO icon
Cisco
CSCO
+$6.05M
3
NVDA icon
NVIDIA
NVDA
+$3M
4
TRV icon
Travelers Companies
TRV
+$2.49M
5
AXP icon
American Express
AXP
+$1.07M

Top Sells

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$16.9M
2
JPM icon
JPMorgan Chase
JPM
+$7.16M
3
MA icon
Mastercard
MA
+$4.01M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.2M
5
SOLS
Solstice Advanced Materials
SOLS
+$1.85M

Sector Composition

Rank Sector Weight
1 Industrials 20.74%
2 Financials 18.47%
3 Technology 18.41%
4 Consumer Discretionary 15.76%
5 Healthcare 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$19.3M 1.59%
160,179
– –
LIN icon
27
Linde
LIN
$237B
$17.7M 1.46%
35,799
+304
+0.9% +$143K
XOM icon
28
ExxonMobil
XOM
$651B
$16.5M 1.36%
97,180
– –
MDT icon
29
Medtronic
MDT
$107B
$14.7M 1.21%
169,890
+500
+0.3% +$47.9K
NVDA icon
30
NVIDIA
NVDA
$5.01T
$14.7M 1.21%
84,120
+16,361
+24% +$3M
DIS icon
31
Walt Disney
DIS
$165B
$12.8M 1.05%
132,796
+851
+0.6% +$89.9K
NKE icon
32
Nike
NKE
$61.9B
$10M 0.83%
189,994
+5,057
+3% +$307K
EMR icon
33
Emerson Electric
EMR
$82.9B
$8.99M 0.74%
68,585
– –
REGN icon
34
Regeneron Pharmaceuticals
REGN
$68.8B
$8.39M 0.69%
10,856
+10,542
+3,357% +$8.07M
CVX icon
35
Chevron
CVX
$388B
$8.37M 0.69%
40,433
-220
-0.5% -$40.1K
MCD icon
36
McDonald's
MCD
$188B
$8.36M 0.69%
26,901
-419
-2% -$133K
CSCO icon
37
Cisco
CSCO
$450B
$7.55M 0.62%
97,254
+77,343
+388% +$6.05M
ABBV icon
38
AbbVie
ABBV
$458B
$6.67M 0.55%
30,656
– –
CAC icon
39
Camden National
CAC
$924M
$6.56M 0.54%
138,339
-1,020
-0.7% -$47.8K
NEE icon
40
NextEra Energy
NEE
$187B
$6.36M 0.52%
68,424
– –
NUE icon
41
Nucor
NUE
$56.4B
$6.34M 0.52%
37,465
– –
MTB icon
42
M&T Bank
MTB
$36.2B
$6.19M 0.51%
29,950
– –
SHEL icon
43
Shell
SHEL
$245B
$6.15M 0.51%
66,176
– –
AMGN icon
44
Amgen
AMGN
$203B
$5.01M 0.41%
14,240
– –
DMRC icon
45
Digimarc Corp
DMRC
$133M
$4.12M 0.34%
838,695
+157,878
+23% +$877K
STX icon
46
Seagate
STX
$193B
$3.54M 0.29%
9,025
– –
GOOG icon
47
Alphabet (Google) Class C
GOOG
$3.9T
$3.08M 0.25%
10,724
-10,180
-49% -$3.2M
GE icon
48
GE Aerospace
GE
$367B
$2.92M 0.24%
10,299
– –
PG icon
49
Procter & Gamble
PG
$343B
$2.86M 0.24%
19,804
+144
+0.7% +$21.8K
AXP icon
50
American Express
AXP
$223B
$2.81M 0.23%
9,291
+3,204
+53% +$1.07M
1
2
3 4 5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q1 2026 Portfolio in Review

As of Q1 2026, Kimelman & Baird held 275 positions worth $1.22B, down 6.6% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Kimelman & Baird's Q1 2026 filing shows 12 new, 27 increased, 50 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 8,514 shares worth $2.48M. The largest sale was Norfolk Southern, an estimated $16.9M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q1 2026 buy was Travelers Companies: 8,514 shares worth $2.48M.
  • Kimelman & Baird added most to Regeneron Pharmaceuticals in Q1 2026, an estimated $8.07M increase.
  • Kimelman & Baird's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $16.9M.
  • Kimelman & Baird fully exited Exact Sciences in Q1 2026, selling an estimated $203K.
  • Kimelman & Baird's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2026.
  • Kimelman & Baird opened 12 new positions and closed 12 in Q1 2026.
  • Kimelman & Baird's portfolio value fell 6.6% quarter-over-quarter to $1.22B.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.